基于氨酸的控制/目标传递系统:形成,控制释放和应用
Yanhong Luo1, Liangbin Wang1, Guanghui Li1
1Guangdong Provincial Key Laboratory of Lingnan Specialty Food Science and Technology, Key Laboratory of Green Processing and Intelligent Manufacturing of Lingnan Specialty Food, Ministry of Agriculture, Guangzhou 510225, China; College of Light Industry and Food Sciences, Zhongkai University of Agriculture and Engineering, Guangzhou 510225, China.
Food chemistry
|March 6, 2026
概括
氨酸 (HA) 系统由于其生物相容性和准能力,在医药和食品中提供了多方面的应用. 未来的研究重点是智能HA输送系统,以提高治疗和营养效益.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 氨酸 (HA) 是一种天然的多糖,具有出色的生物相容性,剪切稀释性和CD44受体向性.
- 这些特性使HA成为各种生物活性输送系统的有价值的核心材料.
- HA的多功能性跨越生物医学和食品工业应用.
研究的目的:
- 审查基于氨酸的输送系统的设计,控制释放机制和各种应用.
- 突出HA在向治疗,组织再生和增强营养递送中的作用.
- 探索先进的HA系统的未来方向和安全考虑.
主要方法:
- 对生物医学和食品工业中基于HA的系统的文献综述.
- 分析HA的特性,影响其在药物输送和生物材料中的使用.
- 综合有关癌症治疗,骨修复和营养药物输送等应用的信息.
主要成果:
- HA载体有助于向癌症治疗和骨缺陷修复.
- 3D打印的HA水凝可以控制药物输送和骨再生.
- 酸微针,纳米乳液和可注射的水凝可增强皮肤间的吸收和软组织的增强.
- HA-凝微囊和皮克林乳液改善了益生菌和黄素的稳定性和生物可用性.
- HA系统在营养药物交付和增强食品产品功能方面显示出潜力.
结论:
- 基于氨酸的系统在生物医学中显示出针对性疗法和组织再生的巨大潜力.
- 在食品工业中,HA增强活性化合物的稳定性和生物可用性.
- 未来的发展应该专注于智能,多功能HA传递系统和严格的安全评估.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
58
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
58
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
58
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
58
01:23Modified-Release Drug Delivery Systems: Classification
130
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
130
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
67
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
67
01:24Modified-Release Drug Delivery Systems: Site-Targeted
59
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
59
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
67
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
67